InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,433.74
(
0.23%
)
US TECH 100
19,089.60
(
0.65%
)
Dow Jones
38,647.10
(
-0.17%
)
Brent Oil
82.16
(
0.22%
)
Bitcoin
67,067.08
(
0.46%
)
Post# of 381412
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

RIGATONI

Send PM Follow Ignore
Followers 1609
Posts 120512
Boards Moderated 3
Alias Born 07/09/2003

RIGATONI

Member Level

Re: RIGATONI post# 380651

Thursday, 05/16/2024 9:06:31 AM

Thursday, May 16, 2024 9:06:31 AM

Post# of 381412
“Q3 showed us that the pharmaceutical market is thriving. Driven by our Genefic Specialty Pharmacy subsidiary,


our health segment saw $8.6 million in revenue—up $4.2 million from the previous quarter—accounting for the lion’s share of the company's overall revenue,” according to Dalrada CEO and Chairman, Brian Bonar.

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up